Inovalis Real Estate Investment Trust (TSE:INO) – Equities research analysts at National Bank Financial upped their FY2018 EPS estimates for shares of Inovalis Real Estate Investment Trust in a research report issued on Thursday. National Bank Financial analyst M. Kornack now anticipates that the company will post earnings of $0.92 per share for the year, up from their prior estimate of $0.90.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2017/06/16/inovalis-real-estate-investment-trust-ino-to-post-fy2018-earnings-of-0-92-per-share-national-bank-financial-forecasts-updated-updated-updated.html.
About Inovalis Real Estate Investment Trust
Inovio Pharmaceuticals, Inc (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company’s DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases.
Receive News & Ratings for Inovalis Real Estate Investment Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalis Real Estate Investment Trust and related companies with MarketBeat.com's FREE daily email newsletter.